Prognostic_factors_in_advanced_head_and_neck_cancer_patients_undergoing_multimodality_therapy._A_retrospective_analysis_was_performed_to_investigate_potential_prognostic_factors_for_complete_remission_to_neoadjuvant_chemotherapy_and_overall_survival_in_patients_with_previously_untreated_stage_III_and_stage_IV_head_and_neck_cancer._Eighty_consecutive_patients_were_treated_in_one_of_two_studies_investigating_three_or_four_courses_of_neoadjuvant_chemotherapy._Before_local_therapy_and_surgery_and/or_radiotherapy,_29%_attained_a_complete_remission._No_strong_significant_and_independent_predictor_of_complete_remission_was_identified._Only_nodal_stage_(N)_was_found_moderately_associated_with_complete_remission_(p_=_0.06)._Node-negative_patients_had_higher_remission_rates._Less_important_predictors_were_tumor_stage_(T)_and_site_of_disease;_nasopharyngeal_patients_had_superior_remission_rates_(56%)._With_a_median_followup_of_45_months_and_estimated_3-year_survival_rate_of_38%_(median_23.7_months),_individual_factors_predictive_of_survival_included_pretherapy_weight_loss,_performance_status,_alcohol_use,_pretherapy_serum_albumin_level,_site_of_disease,_and_N_stage._In_multivariate_testing_weight_loss_was_identified_as_the_strongest_independent_predictor_of_survival_(p_less_than_0.0001)_and_surpassed_other_health_status_measures,_such_as_performance_status_and_serum_albumin_level._In_addition,_N_stage_(p_=_0.019)_and_alcohol_use_(p_=_0.017)_were_found_to_be_predictive._A_cross-classification_by_N_stage_and_weight_loss_revealed_risk_groups_with_distinctly_different_prognoses,_which_may_be_useful_for_design_and_analysis_in_future_trials.